Structural Diversity and Anticancer Activity of Marine-Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast Cancer.
Structural Diversity and Anticancer Activity of Marine-Derived Elastase Inhibitors: Key Features and Mechanisms Mediating the Antimetastatic Effects in Invasive Breast Cancer.
复制标题
DOI:
10.1002/cbic.201700627
复制
发表时间:
2018-04-16
期刊:
影响因子:
--
通讯作者:
Luesch H
中科院分区:
文献类型:
--
作者:
Al-Awadhi FH;Paul VJ;Luesch H
Three new 3-amino-6-hydroxy-2-piperidone (Ahp)-containing cyclic depsipeptides named loggerpeptins A–C (1–3) along with molassamide (4) were discovered from a marine cyanobacterium, extending the structural diversity of this prevalent scaffold of cyanobacterial serine protease inhibitors. Molassamide (4), containing the 2-amino-butenoic (Abu) unit in the cyclic core, was the most potent and selective analogue against human neutrophil elastase (HNE). Given the growing evidence supporting the role of HNE in breast cancer progression and metastasis, we assessed the cellular effects of compounds 3 and 4 in the context of targeting invasive breast cancer. Both compounds inhibited the cleavage of the elastase substrate CD40 in biochemical assays; however, only 4 exhibited significant cellular activity. Since CD40 and other receptor proteolytic processing culminates in NFKB activation, we assessed the effects on the expression of target genes, including ICAM-1. ICAM-1 is also a direct target of elastase, and in our studies compound 4 attenuated both elastase-induced ICAM-1 gene expression and ICAM-1 proteolytic processing by elastase, revealing a potential dual effect on migration through modulation of gene expression and proteolytic processing. Molassamide (4) specifically inhibited the elastase-mediated migration of highly invasive triple negative breast cancer cells. The chemical exploration of a marine cyanobacterium collected from Loggerhead Key, Florida led to the discovery of three new elastase inhibitors, loggerpeptins A–C (1–3), along with molassamide (4) that may have a value in the context of cancer. Molassamide (4), the most potent analogue, was shown to inhibit the cleavage of CD40, the expression and cleavage of its downstream target ICAM-1, reverse HNE-induced morphological changes as well as the elastase-induced migration of invasive breast cancer cells.
登录
查看更多内容
影响因子:
11.2
作者:
Mittendorf EA;Alatrash G;Qiao N;Wu Y;Sukhumalchandra P;St John LS;Philips AV;Xiao H;Zhang M;Ruisaard K;Clise-Dwyer K;Lu S;Molldrem JJ
通讯作者:
Molldrem JJ
影响因子:
4.2
作者:
Duan, Jianhui;Xiaokaiti, Yilixiati;Li, Xuejun
通讯作者:
Li, Xuejun
影响因子:
3.2
作者:
Aikawa, Naoki;Ishizaka, Akitoshi;Kawasaki, Yasushi
通讯作者:
Kawasaki, Yasushi
影响因子:
5.4
作者:
Al-Awadhi FH;Salvador LA;Law BK;Paul VJ;Luesch H
通讯作者:
Luesch H
影响因子:
11.2
作者:
Aronchik, Ida;Bjeldanes, Leonard F.;Firestone, Gary L.
通讯作者:
Firestone, Gary L.